GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Caplin Point Laboratories Ltd (BOM:524742) » Definitions » Price-to-Owner-Earnings

Caplin Point Laboratories (BOM:524742) Price-to-Owner-Earnings : 31.16 (As of May. 26, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Caplin Point Laboratories Price-to-Owner-Earnings?

As of today (2024-05-26), Caplin Point Laboratories's share price is ₹1302.35. Caplin Point Laboratories's Owner Earnings per Share (TTM) ended in Mar. 2024 was ₹41.80. It's Price-to-Owner-Earnings for today is 31.16.


The historical rank and industry rank for Caplin Point Laboratories's Price-to-Owner-Earnings or its related term are showing as below:

BOM:524742' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 3.93   Med: 21.59   Max: 94.63
Current: 32.02

During the past 13 years, the highest Price-to-Owner-Earnings of Caplin Point Laboratories was 94.63. The lowest was 3.93. And the median was 21.59.


BOM:524742's Price-to-Owner-Earnings is ranked worse than
57.79% of 417 companies
in the Drug Manufacturers industry
Industry Median: 27.13 vs BOM:524742: 32.02

As of today (2024-05-26), Caplin Point Laboratories's share price is ₹1302.35. Caplin Point Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹60.05. Therefore, Caplin Point Laboratories's PE Ratio for today is 21.69.

As of today (2024-05-26), Caplin Point Laboratories's share price is ₹1302.35. Caplin Point Laboratories's EPS without NRI for the trailing twelve months (TTM) ended in was ₹60.05. Therefore, Caplin Point Laboratories's PE Ratio without NRI for today is 21.69.

During the past 13 years, Caplin Point Laboratories's highest PE Ratio without NRI was 61.93. The lowest was 4.70. And the median was 20.10.


Caplin Point Laboratories Price-to-Owner-Earnings Historical Data

The historical data trend for Caplin Point Laboratories's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caplin Point Laboratories Price-to-Owner-Earnings Chart

Caplin Point Laboratories Annual Data
Trend Jun15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 54.04 11.44 15.71 16.65 31.52

Caplin Point Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.65 - - - 31.52

Competitive Comparison of Caplin Point Laboratories's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Caplin Point Laboratories's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Caplin Point Laboratories's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Caplin Point Laboratories's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Caplin Point Laboratories's Price-to-Owner-Earnings falls into.



Caplin Point Laboratories Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Caplin Point Laboratories's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=1302.35/41.80
=31.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Caplin Point Laboratories  (BOM:524742) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Caplin Point Laboratories Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Caplin Point Laboratories's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Caplin Point Laboratories (BOM:524742) Business Description

Traded in Other Exchanges
Address
Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096
Caplin Point Laboratories Ltd is the India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, liquid orals, dry powder, soft gels, penems injections, suppositories. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops. The business of the company is organized into the following product segments, Antibiotics, Nsaids, Ophthalmics, Pain Management, and Antiulcers. Its products have a presence in the Latin American and African markets.

Caplin Point Laboratories (BOM:524742) Headlines

No Headlines